1. Home
  2. ATR vs VTRS Comparison

ATR vs VTRS Comparison

Compare ATR & VTRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATR
  • VTRS
  • Stock Information
  • Founded
  • ATR 1992
  • VTRS 1961
  • Country
  • ATR United States
  • VTRS United States
  • Employees
  • ATR N/A
  • VTRS N/A
  • Industry
  • ATR Plastic Products
  • VTRS Medicinal Chemicals and Botanical Products
  • Sector
  • ATR Industrials
  • VTRS Health Care
  • Exchange
  • ATR Nasdaq
  • VTRS Nasdaq
  • Market Cap
  • ATR 10.2B
  • VTRS 10.6B
  • IPO Year
  • ATR 1993
  • VTRS N/A
  • Fundamental
  • Price
  • ATR $160.93
  • VTRS $9.41
  • Analyst Decision
  • ATR Strong Buy
  • VTRS Hold
  • Analyst Count
  • ATR 4
  • VTRS 5
  • Target Price
  • ATR $182.50
  • VTRS $10.40
  • AVG Volume (30 Days)
  • ATR 332.8K
  • VTRS 9.0M
  • Earning Date
  • ATR 07-31-2025
  • VTRS 08-07-2025
  • Dividend Yield
  • ATR 1.12%
  • VTRS 5.10%
  • EPS Growth
  • ATR 17.39
  • VTRS N/A
  • EPS
  • ATR 5.47
  • VTRS N/A
  • Revenue
  • ATR $3,554,747,000.00
  • VTRS $14,330,200,000.00
  • Revenue This Year
  • ATR $4.36
  • VTRS N/A
  • Revenue Next Year
  • ATR $5.24
  • VTRS $1.85
  • P/E Ratio
  • ATR $29.43
  • VTRS N/A
  • Revenue Growth
  • ATR 0.34
  • VTRS N/A
  • 52 Week Low
  • ATR $130.85
  • VTRS $6.85
  • 52 Week High
  • ATR $178.03
  • VTRS $13.55
  • Technical
  • Relative Strength Index (RSI)
  • ATR 61.06
  • VTRS 59.17
  • Support Level
  • ATR $155.23
  • VTRS $8.84
  • Resistance Level
  • ATR $164.28
  • VTRS $9.44
  • Average True Range (ATR)
  • ATR 2.58
  • VTRS 0.22
  • MACD
  • ATR 0.31
  • VTRS 0.01
  • Stochastic Oscillator
  • ATR 68.78
  • VTRS 95.00

About ATR AptarGroup Inc.

Headquartered in Crystal Lake, Illinois, AptarGroup is a leading global supplier of dispensing systems such as aerosol valves, pumps, closures, and elastomer packaging components to the consumer goods and pharmaceutical markets. With the bulk of its annual net sales coming from Europe (49% of sales) and the United States (32%), Aptar aims to increase its presence in Asia (11%) and Latin America (8%). It operates three business segments, Pharma, Beauty, and Closures. Pharma generates over two thirds of group profits.

About VTRS Viatris Inc.

Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. Remaining 60% of sales is derived from its portfolio of legacy products which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.

Share on Social Networks: